医学
疾病
精密医学
2型糖尿病
生物信息学
遗传关联
糖尿病
光学(聚焦)
全基因组关联研究
表型
遗传变异
重症监护医学
个性化医疗
家庭医学
梅德林
遗传学
计算生物学
基因型
内科学
生物
基因
单核苷酸多态性
病理
内分泌学
环境卫生
人口
作者
Daniel Seung Kim,Anna L. Gloyn,Joshua W. Knowles
标识
DOI:10.1016/j.jacc.2021.03.346
摘要
Type 2 diabetes (T2D) is highly prevalent and is a strong contributor for cardiovascular disease. However, there is significant heterogeneity in disease pathogenesis and the risk of complications. Enormous progress has been made in our ability to catalog genetic variation associated with T2D risk and variation in disease-relevant quantitative traits. These discoveries hold the potential to shed light on tractable targets and pathways for safe and effective therapeutic development, but the promise of precision medicine has been slow to be realized. Recent studies have identified subgroups of individuals with differential risk for intermediate phenotypes (eg, lipid levels , fasting insulin, body mass index) that contribute to T2D risk, helping to account for the observed clinical heterogeneity. These “partitioned genetic risk scores” not only have the potential to identify patients at greatest risk of cardiovascular disease and rapid disease progression , but also could aid patient stratification bridging the gap toward precision medicine for T2D. • The association of T2D with CVD accounts for substantial morbidity and mortality. • Genetic associations delineate mechanistic pathways influencing T2D phenotypes with implications for pathogenesis and treatment. • Further work is needed to characterize these genetic links across diverse ancestries.
科研通智能强力驱动
Strongly Powered by AbleSci AI